Valion Bio, Inc. VBIO
Set alert
0.55 USD -0.07 -10.83%
At close · Oct 30
0.53 -0.02 -3.56%
After hours · Oct 30, 7:32 PM ET
0.5237 Day range 0.6026
0.55 52-week range 66.50
- YTD
- -98.48%
- 1 year
- -99.12%
- Open
- 0.60
- Prev close
- 0.6168
- Mkt cap
- 1.15M
- Vol
- 219.94K
- Avg vol
- 1.98M
- EPS
- -177.91
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.5237
- High
- 0.6026
Financials — quick view
VBIO Revenue — quarterly 0
VBIO Net income — quarterly -7.10M
VBIO EPS — quarterly -54.00
News
- 12 Health Care Stocks Moving In Friday's After-Market Session
- Valion Bio Announces That The Armed Forces Radiobiology Research Institute Will Evaluate The Therapeutic Efficacy Of Entolimod
- Valion Bio Announces Final Data From Entolimod Study For Hematopoietic And Gastrointestinal Forms Of Acute Radiation Syndrome; AFRRI Study Found No Evidence Of Treatment-Related Toxicity After One Dose Of Entolimod, Supporting Advancement Toward A Fully Funded Therapeutic Study
- Why Celestica Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Valion Bio Confirms Receipt Of Proposed Acquisition Offers For Its Velocity Bioworks; Terms Undisclosed
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- Valion Bio's New Leadership Unveils 30-Day Agenda to Accelerate Clinical Pipeline and Unlock Shareholder Value
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Valion Bio's Velocity Biowork Subsidiary Completes Initial Feasibility Evaluation Of LarmorBio's BioScan-NMR Platform
Your note
Sign in to keep a note on VBIO — it syncs with the Stock Master app.